Semaglo OB SC Injection Injection Pack Image 0.25 mg/0.5 ml 0.25 mg pre-filled syringe: 450.00 Also available as: Indications For Diabetes : Semaglo OB is indicated in- An adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus To reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease For Obesity : An adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of: 30 kg/m 2 or greater (Obesity) or 27 kg/m 2 or greater (Overweight) in the presence of at least one weight-related comorbid condition (e.g
Spotlight has compiled a detailed breakdown of the availability and price of various GLP-1 agonists in South Africa
By combining thiol hyaluronic acid and bioactive silver lignin nanoparticles, a hybrid nanocomposite hydrogel was prepared with excellent antioxidant activity and chronic wound healing promotion (Perez-Rafael et al., 2021)
Single vial, single reconstitution, single draw per session delivers proportional amounts of all three peptides
Results After propensity score matching, the semaglutide group demonstrated significantly better outcomes for HbA1c reduction and weight loss and improvements in systolic blood pressure (SBP), low-density lipoprotein cholesterol (LDL-C), and liver function than the control group
